What is the second generation of corona vaccine? Britain sets the date for granting it

 Britain has become the first country in the world to allow the new generation of the vaccine against the “Covid-19” disease, which is caused by the Corona virus, setting a start date for giving it to the population. And the British network, “Sky News”, stated that the new vaccine targets the original strain of the Corona virus, as well as the fake “Omicron”.

The “Moderna” vaccine was given the green light by the Medicines and Healthcare products Regulatory Agency in Britain, after this authority found that this new vaccine meets its standards for safety, quality and efficacy. The new vaccine is known as the "original Spivax Bivalent and Omicron", and contains 25 micrograms of the vaccine intended for "Omicron", and a similar proportion of the vaccine against the original strain.

In short, this vaccine works to counter two types of infection, so it is known as "dual-target" or "dual-target", and work on its development by international pharmaceutical companies has begun since the emergence of the "Omicron" mutant. The "Sky News" reporter says that the new generation of Corona vaccines includes a built-in insurance against the development of the Corona virus.

The new generation of these vaccines is being developed by "Pfizer" in addition to Moderna, and it is not far from the first generation, as it works to launch an immune response against the original strain known as "Wuhan", but it adds protection against copies of "Omicron". , which has become dominant in the world.

British authorities said the vaccine will be available to those aged 18 and over, as part of the country's booster programme, in the fall. And the British Minister of Health, Steve Barclay, stated that those qualified to take the vaccine will be contacted from early September.

He stressed that vaccines are the best means of defense against "Covid-19" disease, stressing that the new vaccine is safe and effective and will increase the range of immunity and strengthen our bodies against some mutations.

In an official statement, the CEO of the Medicines and Healthcare products Regulatory Agency, John Ren, wrote that clinical trials showed that the new vaccine confers strong immunity against the mutated “Omicron PA1”, the original strain of Corona.

Ren added that the first generation of anti-Corona vaccines was used to provide people with the necessary protection against disease and save life, while the second generation helps us protect ourselves from disease at a time when the virus is evolving.